Initiatives for Improving Access to Medicines for Non-communicable Diseases

Flexible Pricing Policy in Emerging and Developing Countries

In addition to the patient contribution through innovative new drug development and sales, Eisai has established a core strategy consisted of affordable pricing, provision of disease solutions, public-private partnerships and local partnerships, to contribute to improving access to medicines in emerging and developing countries.

Flexible Pricing Policy in Emerging and Developing Countries

Approval Status of Global Products

Eisai strives to bring products to many patients who need them all over the world. Please visit to see the approval status of Eisai global products in each country and region.

Approval Status of Global Products

Recent Activities

Eisai CEO Haruo Naito Delivered Speech at G7 Health Follow-up Side Event
—Eisai's Initiatives toward Impact Quantification and Expectations for Impact Investment—

On September 21, 2023, Eisai’s CEO Haruo Naito participated in the G7 Health Follow-up Side Event held along with the United Nations General Assembly High-Level Meeting in New York, the United States,…

Fostering the Next Generation Leaders in Global Health
—Attending as a Judge in “Policy Pitch”, a Policy Proposal Event by Gen Z—

“Policy Pitch”, an event hosted by PoliPoli Inc. where Gen Z make policy proposals, was held on August 7, 2023. Sayoko Sasaki, Eisai’s Vice President in charge of ESG, attended as a judge.
Policy…

Participation in the Access Accelerated Initiatives

Eisai is participating in Access Accelerated, a global partnership to advance access to non-communicable diseases (NCDs) prevention, treatment, and care in low and lower-middle income countries.
At…

All Activities

Related Information

Our Concept for Access to Medicines

Initiatives for Elimination of Neglected Tropical Diseases

Research & Development for Improving Access to Medicines

Flexible Pricing Policy in Emerging and Developing Countries

Approval Status of Global Products

Recent Activities

Eisai CEO Haruo Naito Delivered Speech at G7 Health Follow-up Side Event—Eisai's Initiatives toward Impact Quantification and Expectations for Impact Investment—

Fostering the Next Generation Leaders in Global Health—Attending as a Judge in “Policy Pitch”, a Policy Proposal Event by Gen Z—

Participation in the Access Accelerated Initiatives

Related Information

Related Links

Eisai CEO Haruo Naito Delivered Speech at G7 Health Follow-up Side Event
—Eisai's Initiatives toward Impact Quantification and Expectations for Impact Investment—

Fostering the Next Generation Leaders in Global Health
—Attending as a Judge in “Policy Pitch”, a Policy Proposal Event by Gen Z—